Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients-Reference-Cited by-同舟云学术

Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients

Published:2024-03-04 Issue: Volume: Page:26-36
ISSN:1300-7777
Container-title:Turkish Journal of Hematology
language:
Short-container-title:Tjh

Author:

Narlı Özdemir Zehra,İpek Yıldız,Patir Pusem,Ermiş Gözde,Çiftçiler Rafiye,Özmen Deniz,Baysal Mehmet,Gürsoy Vildan,Yıldızhan Esra,Güven Serkan,Ercan Tarık,Elibol Tayfun,Mersin Sinan,Genç Eylem,Davulcu Eren Arslan,Karakuş Volkan,Erkut Nergiz,Güneş Gürsel,Diz Küçükkaya Reyhan,Eşkazan Ahmet Emre

Publisher

Galenos Yayinevi

Reference39 articles.

1. Somatic mutations of calreticulin in myeloproliferative neoplasms;Klampfl;N Engl J Med,2013

2. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2;Nangalia;N Engl J Med,2013

3. Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients;Haider;Am J Hematol,2016

4. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes;Rumi;Blood,2014

5. CALR versus JAK2 mutated essential thrombocythaemia - a report on 141 patients;Trifa;Br J Haematol,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloproliferative Neoplasm Symptom Assessment Total Symptom Score (MPN-SAF TSS) in Chronic Myeloproliferative Neoplasms, Related with Genetic Burden, and Thrombosis;Turkish Journal of Hematology;2024-05-27